Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stephanie Saw"'
Autor:
Johan W.K. Chan, Daniel Peh, Wei Chong Tan, Hui Shan Tan, Quan Sing Ng, Tanujaa Rajasekaran, Yi Lin Teh, Stephanie Saw, Wan Ling Tan, Gillianne Lai, Amit Jain, Ravindran Kanesvaran
Publikováno v:
Journal of Clinical Oncology. 41:632-632
632 Background: Non-clear cell RCC (nccRCC) represents a heterogenous group of tumors which is less well studied than clear cell RCC. Clinical data supporting the treatment of nccRCC are still based on phase 2 studies and clinical trials conducted in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b11781653738d96b0e7d75295da90126
https://doi.org/10.1200/jco.2023.41.6_suppl.632
https://doi.org/10.1200/jco.2023.41.6_suppl.632
Autor:
Stephanie Saw, Gillianne Lai, Aaron C. Tan, Siqin Zhou, Mei-Kim Ang, Wan-Teck Lim, Ravindran Kanesvaran, Wan Ling Tan, Tanujaa Rajasekaran, Johan Chan, Yi Lin Teh, Boon-Hean Ong, Angela M. Takano, Eng Huat Tan, Sze Huey Tan, Daniel Shao-Weng Tan
Publikováno v:
Journal of Clinical Oncology. 40:8527-8527
8527 Background: Adjuvant Atezolizumab was recently approved in stage II-IIIA non-small cell lung cancer (NSCLC) with PD-L1 ≥1%. However, disease-free survival (DFS) benefit was mainly driven by PD-L1 ≥50% and among EGFR-mutated subgroup, atezoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc62a8c22f58d0106a6ba8c51ca96492
https://doi.org/10.1200/jco.2022.40.16_suppl.8527
https://doi.org/10.1200/jco.2022.40.16_suppl.8527
Publikováno v:
Breast cancer research and treatment. 177(1)
This study aimed to identify patterns of relapse after neoadjuvant chemotherapy (NAC) for breast cancer to refine follow-up recommendations. Retrospective analysis on 523 breast cancer patients treated with NAC at two public hospitals in Singapore be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a89849596c9a9993cb21bf71fb96e1a
https://pubmed.ncbi.nlm.nih.gov/31147984
https://pubmed.ncbi.nlm.nih.gov/31147984
Publikováno v:
European Journal of Cancer. 81:237-239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4abc37ddda7613fb6a2472119b7352d
https://doi.org/10.1016/j.ejca.2017.03.026
https://doi.org/10.1016/j.ejca.2017.03.026